Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Reese

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Medical Examiner (Philadelphia, Pa.)|December 20, 2023
Ship Fever at the Bellevue HospitalD M Reese, C A Lee
Current Opinion in Oncology|June 7, 2000
An update on prostate cancer researchE J Small, D M Reese
Drugs|January 5, 2002
Treatment options in hormone-refractory prostate cancer: current and future approachesK A Harris, D M Reese
Cancer|March 16, 2000
Infusional floxuridine-based therapy for patients with metastatic renal cell carcinomaD M Reese, M Corry, E J Small
Seminars in Oncology|December 22, 1999
Hormone-refractory prostate cancer: an evolving standard of careE J Small, D M Reese, N J Vogelzang
Investigational New Drugs|July 30, 1999
A phase II trial of irinotecan in hormone-refractory prostate cancerD M Reese, S Tchekmedyian, Y Chapman, et al.
Seminars in Oncology|October 31, 2001
Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancerE J Small, R Bok, D M Reese, et al.
Urology|August 8, 2001
Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancerG D Grossfeld, U B Chaudhary, D M Reese, et al.
Urology|February 2, 2000
Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysisV S Tigrani, D M Reese, E J Small, et al.
American Journal of Clinical Oncology|August 26, 1998
Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literatureA A Safa, D M Reese, D M Carter, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Medical Examiner (Philadelphia, Pa.)|December 20, 2023
Ship Fever at the Bellevue HospitalD M Reese, C A Lee
Current Opinion in Oncology|June 7, 2000
An update on prostate cancer researchE J Small, D M Reese
Drugs|January 5, 2002
Treatment options in hormone-refractory prostate cancer: current and future approachesK A Harris, D M Reese
Cancer|March 16, 2000
Infusional floxuridine-based therapy for patients with metastatic renal cell carcinomaD M Reese, M Corry, E J Small
Seminars in Oncology|December 22, 1999
Hormone-refractory prostate cancer: an evolving standard of careE J Small, D M Reese, N J Vogelzang
Investigational New Drugs|July 30, 1999
A phase II trial of irinotecan in hormone-refractory prostate cancerD M Reese, S Tchekmedyian, Y Chapman, et al.
Seminars in Oncology|October 31, 2001
Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancerE J Small, R Bok, D M Reese, et al.
Urology|August 8, 2001
Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancerG D Grossfeld, U B Chaudhary, D M Reese, et al.
Urology|February 2, 2000
Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysisV S Tigrani, D M Reese, E J Small, et al.
American Journal of Clinical Oncology|August 26, 1998
Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literatureA A Safa, D M Reese, D M Carter, et al.
Pageof 3